1.FDG-PET/CT Complements Bone Scan with Respect to the Detection of Skip Metastasis of Osteosarcoma: A Case Report.
Gi Jeong CHEON ; Jae Gol CHOE ; In Jung CHAE ; Dae Hee LEE ; Sang Heon SONG ; Myo Jong KIM ; Jong Hoon PARK
The Journal of the Korean Bone and Joint Tumor Society 2012;18(1):45-49
Skip lesion is not uncommon feature in osteosarcoma and considered to be importantly associated with poor prognosis factor, and thus, should be excised with the main mass. The accurate pre-operative evaluation of the intramedullary extent of osteosarcoma is essential, because it determines the level of bone resection. Among the reliable detection methods, bone scan has a drawback of high rate of false negative results and regional MRI has a difficulty to cover the whole involved lesions without clinical suspicion. The authors report a case of osteosarcoma of the distal femur with a proximal skip lesion that was not detected by either regional MR imaging or by bone scan, but which was visualized by FDG-PET/CT.
Complement System Proteins
;
Femur
;
Neoplasm Metastasis
;
Osteosarcoma
;
Prognosis
2.Fibrocartilaginous Intramedullary Bone Forming Tumor of the Distal Femur Mimicking Osteosarcoma.
Sang Heon SONG ; Hanna LEE ; Hae Ryong SONG ; Myo Jong KIM ; Jong Hoon PARK
Journal of Korean Medical Science 2013;28(4):631-635
Fibrocartilaginous dysplasia (FCD) has occasionally led to a misdiagnosis and wrong decision which can significantly alter the outcome of the patients. A 9-yr-old boy presented with pain on his left distal thigh for 6 months without any trauma history. Initial radiographs showed moth eaten both osteolytic and osteosclerotic lesions and biopsy findings showed that the lesion revealed many irregular shaped and sclerotic mature and immature bony trabeculae. Initial diagnostic suggestions were varied from the conventional osteosarcoma to low grade central osteosarcoma or benign intramedullary bone forming lesion, but close observation was done. This study demonstrated a case of unusual fibrocartilaginous intramedullary bone forming tumor mimicking osteosarcoma, so that possible misdiagnosis might be made and unnecessary extensive surgical treatment could be performed. In conclusion, the role of orthopaedic oncologist as a decision maker is very important when the diagnosis is uncertain.
Bone and Bones/*radiography
;
Child
;
Diagnosis, Differential
;
Femur/radiography
;
Fibrocartilage/*radiography
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Osteosarcoma/diagnosis/radiography
3.A Genetic Study in a Patient with Incontinentia Pigmenti.
Myo Jing KIM ; Ki Yeol LEE ; Chang Seok KI ; Ki Hoon SONG ; Young Hun KIM
Korean Journal of Dermatology 2011;49(2):164-168
Incontinentia pigmenti (IP) is a rare X-linked dominant, multisystem genodermatosis that affects ectoderm-derived structures. Its cutaneous manifestations are usually subdivided into the vesicular, verrucous, hyperpigmented, and hypopigmented or atrophic stages. IP can also affect other ectoderm-derived structures, such as, hair, nails, teeth, eyes, and the central nervous and musculoskeletal systems. About 80% of IP patients have genomic deletions of exons 4~10 of the NEMO (NF-kappaB-Essential MOdulator) gene, also known as the IKKgamma (gamma-subunit of the inhibitor kappaB kinase), which is essential for the activation of the NF-kappaB pathway. The female infant presented in this case report was born to healthy non-consanguineous parents and showed vesiculopustular eruptions with a NEMO gene rearrangement. No IP case has been previously reported to be related to a NEMO gene mutation in South Korea. In other words, this is the first report to confirm the relation between IP and mutation of the NEMO gene in Koreans.
Exons
;
Eye
;
Female
;
Gene Rearrangement
;
Hair
;
Humans
;
Incontinentia Pigmenti
;
Infant
;
Musculoskeletal System
;
Nails
;
NF-kappa B
;
Parents
;
Republic of Korea
;
Tooth
5.Intussusception and Jejunal Atresia Caused by an Ectopic Pancreas in a Newborn
Han-Sol KIM ; Sun-Young LEE ; Song-Hee HAN ; So-Hyun NAM ; Chae-Ku JO ; Myo-Jing KIM
Neonatal Medicine 2021;28(2):72-76
Ectopic pancreas is defined as an abnormally located pancreatic tissue not sufficiently connected with the normal pancreas, which rarely occurs in neonates. To our knowledge, only a few cases of ectopic pancreas have been reported in newborns in South Korea. We report a case of ectopic pancreas as the cause of intussusception and jejunal atresia in a newborn. This clinical association is extremely rare, and this is the first report in South Korea.
6.Intussusception and Jejunal Atresia Caused by an Ectopic Pancreas in a Newborn
Han-Sol KIM ; Sun-Young LEE ; Song-Hee HAN ; So-Hyun NAM ; Chae-Ku JO ; Myo-Jing KIM
Neonatal Medicine 2021;28(2):72-76
Ectopic pancreas is defined as an abnormally located pancreatic tissue not sufficiently connected with the normal pancreas, which rarely occurs in neonates. To our knowledge, only a few cases of ectopic pancreas have been reported in newborns in South Korea. We report a case of ectopic pancreas as the cause of intussusception and jejunal atresia in a newborn. This clinical association is extremely rare, and this is the first report in South Korea.
7.Conducting and Reporting a Clinical Research Using Korean Healthcare Claims Database
Seonji KIM ; Myo-Song KIM ; Seung-Hun YOU ; Sun-Young JUNG
Korean Journal of Family Medicine 2020;41(3):146-152
An increasing number of studies are using healthcare claims databases to assess healthcare intervention utilization patterns or outcomes in real-world clinical settings. However, methodological issues affecting study design or data analysis can make conducting and reporting these types of studies difficult. This review presents an overview of the types of information contained in claims data, describes some advantages and limitations of using claims data for research purposes, and outlines steps for utilizing the Korea Health Insurance Review and Assessment and National Health Insurance Service databases. The study also reviews epidemiological approaches utilizing healthcare claims databases (including cross-sectional, case-control, case-crossover, and cohort designs) with respect to protocol development, analysis, and reporting of results, and introduces relevant guidelines and checklists, including the Guidelines for Good Pharmacoepidemiology Practices, the Strengthening the Reporting of Observational Studies in Epidemiology checklist, and the Risk of Bias in Nonrandomized Studies of Interventions tool.
8.Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
Min-Taek LEE ; Kwang-Yeol PARK ; Myo-Song KIM ; Seung-Hun YOU ; Ye-Jin KANG ; Sun-Young JUNG
Yonsei Medical Journal 2020;61(9):741-749
Purpose:
Non-vitamin K antagonist oral anticoagulants (NOACs) are widely used in patients with atrial fibrillation (AF) because of their effectiveness in preventing stroke and their better safety, compared with warfarin. However, there are concerns for an increased risk of bleeding associated with concomitant use of non-steroidal anti-inflammatory drugs (NSAIDs) or selective serotonin reuptake inhibitors (SSRIs) with NOACs. In this study, we aimed to evaluate the risk of bleeding events in individuals taking concomitant NSAIDs or SSRIs with NOACs after being diagnosed with AF. Materials and Methods: A nested case-control analysis to assess the safety of NSAIDs and SSRIs among NOAC users with AF was performed using data from Korean National Health Insurance Service from January 2012 to December 2017.Among patients who were newly prescribed NOACs, 1233 cases hospitalized for bleeding events were selected, and 24660 controls were determined.
Results:
The risk of bleeding events was higher in patients receiving concomitant NSAIDs [adjusted odds ratio (aOR) 1.41; 95% confidence interval (CI) 1.24–1.61] or SSRIs (aOR 1.92; 95% CI 1.52–2.42) with NOACs, compared to no use of either drug, respectively.The risk of upper gastrointestinal bleeding was higher in patients receiving concomitant NSAIDs or SSRIs without proton pump inhibitors (PPIs) (NSAIDs: aOR 2.47; 95% CI 1.26–4.83, SSRI: aOR 10.8; 95% CI 2.41–2.48) compared to no use.
Conclusion
When NSAIDs or SSRIs are required for NOAC users with AF, physicians need to monitor bleeding events and consider the use of PPIs, especially for combined use of both drugs or when initiating NOACs treatment.
9.ERK Activation by Fucoidan Leads to Inhibition of Melanogenesis in Mel-Ab Cells.
Yu Seok SONG ; Marie Carmel BALCOS ; Hye Young YUN ; Kwang Jin BAEK ; Nyoun Soo KWON ; Myo Kyoung KIM ; Dong Seok KIM
The Korean Journal of Physiology and Pharmacology 2015;19(1):29-34
Fucoidan, a fucose-rich sulfated polysaccharide derived from brown seaweed in the class Phaeophyceae, has been widely studied for its possible health benefits. However, the potential of fucoidan as a possible treatment for hyperpigmentation is not fully understood. This study investigated the effects of fucoidan on melanogenesis and related signaling pathways using Mel-Ab cells. Fucoidan significantly decreased melanin content. While fucoidan treatment decreased tyrosinase activity, it did not do so directly. Western blot analysis indicated that fucoidan downregulated microphthalmia-associated transcription factor and reduced tyrosinase protein expression. Further investigation showed that fucoidan activated the extracellular signal-regulated kinase (ERK) pathway, suggesting a possible mechanism for the inhibition of melanin synthesis. Treatment with PD98059, a specific ERK inhibitor, resulted in the recovery of melanin production. Taken together, these findings suggest that fucoidan inhibits melanogenesis via ERK phosphorylation.
Blotting, Western
;
Hyperpigmentation
;
Insurance Benefits
;
Melanins
;
Microphthalmia-Associated Transcription Factor
;
Monophenol Monooxygenase
;
Phaeophyta
;
Phosphorylation
;
Phosphotransferases
;
Seaweed
10.Efficacy of testicular sperm chromatin condensation assay using aniline blue-eosin staining in the IVF-ET cycle.
Yong Seog PARK ; Myo Kyung KIM ; Sun Hee LEE ; Jae Won CHO ; In Ok SONG ; Ju Tae SEO
Clinical and Experimental Reproductive Medicine 2011;38(3):142-147
OBJECTIVE: This study was performed to evaluate testicular sperm chromatin condensation using aniline blue-eosin (AB-E) staining and its effects on IVF-ET. METHODS: Chromatin condensation was analyzed using AB-E staining in 27 cases of testicular sperm extraction. There were 19 cases of obstructive azoospermia (OA) and 8 cases of non-obstructive azoospermia (NOA) in IVF-ET. Mature sperm heads were stained red-pink whereas immature sperm heads were stained dark blue. The percentage of sperm chromatin condensation was calculated from the ratio of the number of red-pink sperm to the total number of sperm analyzed. RESULTS: The overall percentages of chromatin condensation in OA and NOA were 31.1+/-11.2% and 26.3+/-14.4%, respectively. The fertilization rate was significant higher in OA than NOA (p<0.05); however, the rates of good embryos and clinical pregnancy did not show statistical differences. In OA and NOA, statistical differences were not observed in the rate of chromatin condensation, fertilization, good embryos, and clinical pregnancy between the pregnant group and non-pregnant group. CONCLUSION: Chromatin condensation is less stable than OA and showed a low fertilization rate in NOA. While there were no significant differences in chromatin condensation results between NOA and OA, we propose that a pattern of decreased chromatin condensation in NOA is one of the factors of low fertilization results requiring further study.
Aniline Compounds
;
Azoospermia
;
Chromatin
;
Embryonic Structures
;
Eosine Yellowish-(YS)
;
Fertilization
;
Humans
;
Pregnancy
;
Sperm Head
;
Spermatozoa